TinyGemsBreaks Archive

WednesdayJun 18, 2025 2:40 pm

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it has signed a memorandum of understanding (MOU) with Yonsei University and Incheon Metropolitan City aimed at accelerating quantum computing adoption in South Korea. Supporting the region’s ambition to become a global quantum technology hub, the MOU outlines plans to work together on research, talent development, and use case exploration across biotechnology, materials science and other sectors. The MOU also facilitates the organizations’ collaborative efforts towards the acquisition of a D-Wave Advantage2™ quantum system at the Yonsei University International Campus in Songdo, Yeonsu-gu, Incheon.…

WednesdayJun 18, 2025 2:23 pm

TinyGemsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Global Launches Hit Broadcast of Ring of Combat via Swerve TV

Authentic Holdings (OTC: AHRO) announced a major licensing agreement between its subsidiary Maybacks Global Entertainment, LLC and Swerve TV, marked by a successful debut broadcast of "Ring of Combat" from the Tropicana in Atlantic City on June 13. The event exceeded expectations, drawing substantial viewership and social media traction across Swerve TV's extensive platform, which reaches 80% of U.S. and Canadian households and over 5 million combat sports fans. The collaboration showcased the legacy of "Ring of Combat," a promotion known for launching 165 fighters into the UFC, including champions like Matt Serra and Merab Dvalishvili. The broadcast success has…

TuesdayJun 10, 2025 1:06 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth

Calidi Biotherapeutics (NYSE American: CLDI) recently announced the appointment of Eric Poma, PhD, as its new chief executive officer and member of the board of directors. The company was featured in an article that reads, “As Calidi Biotherapeutics continues to pioneer targeted antitumor virotherapies, the appointment of Dr. Poma as CEO represents a strategic move to harness experienced leadership for the company’s next phase of growth. His extensive background in oncology, successful track record in fundraising and strategic partnerships, and comprehensive understanding of the biotech landscape position him to effectively steer Calidi’s innovative therapies through clinical development and toward commercialization.” To…

TuesdayJun 10, 2025 9:10 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Transfers Indiana Facility to Settle Legal Dispute with GEM

Mullen Automotive (NASDAQ: MULN) has finalized a settlement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving all outstanding legal disputes. As part of the agreement, Mullen has transferred full ownership of its Mishawaka, Ind. manufacturing facility to GEM, satisfying a prior federal court judgment. The move ends all related litigation and allows Mullen to refocus on its operational goals. To view the full press release, visit https://ibn.fm/LrzjD About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with two United States-based vehicle plants located in…

ThursdayJun 05, 2025 1:39 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic payloads. The company unveiled promising new data on its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology (“ASCO”) Annual Meeting. The announcement reads, “Calidi has previously demonstrated its pioneering efforts in developing an enveloped form of its proprietary oncolytic virus that is significantly more resistant to immune clearance than non-enveloped forms, allowing for systemic delivery and efficacy in syngeneic tumor-bearing pre-clinical models. Calidi has further advanced this technology with CLD-401, its first…

ThursdayJun 05, 2025 9:50 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit

CNS Pharmaceuticals (NASDAQ: CNSP) announced that Chief Medical Officer Sandra Silberman, M.D., Ph.D., will present at the Brain Tumor Biotech Summit hosted by Lenox Hill Hospital’s Department of Neurosurgery on June 5, 2025. Her presentation, titled "The Future and Promise of TPI 287," will highlight CNS’s brain-penetrating taxane candidate, which has shown efficacy in glioblastoma patients, including 3 complete and 9 partial responses in a Phase 1 trial. TPI 287, which has FDA Orphan Drug Designation for gliomas, pediatric neuroblastoma, and progressive supranuclear palsy, may offer a breakthrough in treating CNS tumors by effectively crossing the blood-brain barrier. To view…

ThursdayJun 05, 2025 9:20 am

TinyGemsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Allocate Solar Project Revenue to Bitcoin Treasury Strategy

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has taken its first step toward implementing a Bitcoin treasury strategy by committing net revenue from its 3.79 MW Geddes Solar Power Project to Bitcoin purchases. This initiative places SolarBank among the early renewable energy companies integrating digital assets into corporate finance. The Geddes Project, built on a repurposed landfill, is expected to begin operations by the end of June 2025. CEO Dr. Richard Lu described the move as a strategic blend of stable energy cash flow and Bitcoin’s appreciation potential, with future expansions of the…

TuesdayJun 03, 2025 11:35 am

TinyGemsBreaks – ECGI Holdings Inc. (OTC: ECGI) Backs AI-Focused Startup TrueToForm in First Uplist Ventures Deal

ECGI Holdings (OTC: ECGI), a diversified holding company targeting innovation-led sectors, announced that its investment arm, Uplist Ventures, has completed its first deal by backing AI and 3D computer vision startup TrueToForm. The startup, also backed by MassChallenge, Dartmouth Angels, and Chicago Booth Angels, offers a patented AI body scanning platform designed to reduce e-commerce apparel returns—a $38 billion problem—by creating 97%-accurate digital avatars. ECGI’s own Pacific Saddlery brand already uses TrueToForm for custom fittings. With over 50 clients and a pipeline of 25 brands, TrueToForm is scaling fast. ECGI executives said the deal signals the company’s strategy to support…

TuesdayJun 03, 2025 9:50 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Relaunches FIVE RS EV for German Market with FPF Partnership

Mullen Automotive (NASDAQ: MULN) announced the relaunch of its ultra-high-performance Mullen FIVE RS EV Crossover, with vehicle sales targeted to begin in Germany by December 2025. Following successful 800V battery testing at TUV SUD in Munich, the vehicle is entering on-road validation as part of its final homologation process. Mullen has partnered with Germany-based Faissner Petermeier Fahrzeugtechnik AG (FPF), a veteran automotive engineering and manufacturing firm, to ensure production meets the highest global standards. The FIVE RS boasts a top speed of 200 mph, 0–60 acceleration under two seconds, and over 1,100 horsepower. Mullen plans to expand sales across the EU,…

MondayJun 02, 2025 11:15 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Increases Ownership of Bollinger Motors to 95%, Resolves Receivership

Mullen Automotive (NASDAQ: MULN) has acquired an additional 21% stake in Bollinger Motors, bringing its total ownership to 95% and increasing shareholder equity by approximately $3.5 million. The move follows Mullen’s resolution of outstanding claims and debt that had placed Bollinger under court-ordered receivership, a case now dismissed with prejudice. Bollinger will continue operating independently under Mullen’s ownership, with its commercial EV lineup—led by the all-electric B4 Chassis Cab—receiving full support for sales, service, and warranty. Mullen plans to leverage synergies to accelerate the B4’s development and drive growth within the commercial EV space. To view the full press release, visit…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks